Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants

This study aimed to evaluate the short-term morbidities and efficacy of single-dose prophylactic intravenous ibuprofen for patent ductus arteriosus (PDA) on the first day of life in preterm infants. Data of 69 preterm infants with birth weight < 1250 g and gestational age < 30 weeks admitted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chae Young, Chung, Sung-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351839/
https://www.ncbi.nlm.nih.gov/pubmed/35945745
http://dx.doi.org/10.1097/MD.0000000000029915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351839/
https://www.ncbi.nlm.nih.gov/pubmed/35945745
http://dx.doi.org/10.1097/MD.0000000000029915

Ejemplares similares